- Trials with a EudraCT protocol (91)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (326)
91 result(s) found for: Pediatrics.
Displaying page 1 of 5.
| EudraCT Number: 2015-002675-19 | Sponsor Protocol Number: TMZ-CSF-001 | Start Date*: 2015-10-06 |
| Sponsor Name:Medical University of Vienna, Department of Pediatrics | ||
| Full Title: Pharmacokinetics of temozolomide in cerebrospinal fluid in children with malignant brain tumors | ||
| Medical condition: Recurrent malignant childhood central nervous system tumors | ||
| Disease: | ||
| Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |
| Trial protocol: AT (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2006-004749-40 | Sponsor Protocol Number: PEDMet 2006-1 | Start Date*: 2006-11-20 |
| Sponsor Name:Pediatrics | ||
| Full Title: Glucose metabolism in patients with neurological/neuromuscular diseases. | ||
| Medical condition: Patients with neurological/neuromuscular diseases | ||
| Disease: | ||
| Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
| Trial protocol: BE (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2016-002658-19 | Sponsor Protocol Number: 20016-01 | Start Date*: 2018-06-25 |
| Sponsor Name:Department für Kinder- und Jugendheilkunde, Pädiatrie I | ||
| Full Title: Influence of pulsatile dexamethasone therapy in childhood epilepsia on the immune Systeme. | ||
| Medical condition: Analization of specific immune cells and immune modulation factors in children under pulsatile dexamethasone-therapy. | ||
| Disease: | ||
| Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |
| Trial protocol: AT (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2018-000565-36 | Sponsor Protocol Number: 38/2018 | Start Date*: 2018-06-05 |
| Sponsor Name:University of Oulu | ||
| Full Title: Paracetamol and ibuprofen/indomethacin in closing persistent ductus arteriosus | ||
| Medical condition: Patent ductus arteriosus of a premature infant | ||
| Disease: | ||
| Population Age: Preterm newborn infants, Under 18 | Gender: Male, Female | |
| Trial protocol: FI (Prematurely Ended) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2016-002844-18 | Sponsor Protocol Number: 04071962 | Start Date*: 2017-01-16 |
| Sponsor Name:Medical University of Vienna, Dpt. of Pediatrics | ||
| Full Title: Preventive sublingual immunotherapy for house dust mite sensitized preschool children | ||
| Medical condition: Patients; children at age 4 years with house dust mite IgE sensitization without allergic disease | ||
| Disease: | ||
| Population Age: Children, Under 18 | Gender: Male, Female | |
| Trial protocol: AT (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2017-000174-11 | Sponsor Protocol Number: CN138603 | Start Date*: 2017-04-07 |
| Sponsor Name:Otsuka Pharmaceutical Development & Commercialization, Inc | ||
| Full Title: Safety and Efficacy of Aripiprazole in the Long-Term Maintenance Treatment of Pediatric Subjects with Irritability Associated with Autistic Disorder | ||
| Medical condition: Irritability in Autism Disorder | ||
| Disease: | ||
| Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
| Trial protocol: Outside EU/EEA | ||
| Trial results: View results | ||
| EudraCT Number: 2021-001069-20 | Sponsor Protocol Number: HIDROGUM21 | Start Date*: 2022-01-12 |
| Sponsor Name:Vall d'Hebron Hospital Universitari | ||
| Full Title: Tolerability and acceptance of two oral hydrocortisone compounding formulation for pediatrics | ||
| Medical condition: Adrenal hyperplasia or isolated primary adrenal insufficiency or panhypopituitarism (secondary or tertiary adrenal insufficiency) | ||
| Disease: | ||
| Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
| Trial protocol: ES (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2011-000310-19 | Sponsor Protocol Number: 2011-000310-19 | Start Date*: 2011-08-09 |
| Sponsor Name:Lund University | ||
| Full Title: Fentanyl treatment in newborn infants: A Pharmacokinetic, Pharmacodynamic, and Pharmacogenetic Study (PK/PD model) | ||
| Medical condition: Neonatal Pain | ||
| Disease: | ||
| Population Age: Preterm newborn infants, Newborns, Under 18 | Gender: Male, Female | |
| Trial protocol: SE (Completed) FI (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2007-006602-24 | Sponsor Protocol Number: PNC-2007 | Start Date*: 2008-03-31 |
| Sponsor Name:Department of Pediatrics, Medical and Health Science Center, University of Debrecen | ||
| Full Title: Relative adrenal insufficiency in children with pneumonia and sepsis. Efficacy of i.v. prednisolon for prevention of complication of pneumonia. A prospective, parallel-group, randomised trial. | ||
| Medical condition: Severe complications of bacterial pneumonia i.e. abscess formation, empyema and sepsis in children. Supposed concomittant andrenal insuficiency is also planned to investigate. | ||
| Disease: | ||
| Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
| Trial protocol: HU (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2020-005996-11 | Sponsor Protocol Number: MK-1654-007 | Start Date*: 2021-08-26 | |||||||||||
| Sponsor Name:Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. | |||||||||||||
| Full Title: A Phase 3, Multicenter, Randomized, Partially Blinded, Palivizumab-Controlled Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of MK-1654 in Infants and Children at Increased Risk for S... | |||||||||||||
| Medical condition: Prevention of Respiratory syncytial virus (RSV) infection in infants and children at increased risk for severe RSV disease | |||||||||||||
|
|||||||||||||
| Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Under 18 | Gender: Male, Female | ||||||||||||
| Trial protocol: ES (Trial now transitioned) DE (Trial now transitioned) FI (Trial now transitioned) Outside EU/EEA HU (Trial now transitioned) FR (Trial now transitioned) NO (Trial now transitioned) GR (Trial now transitioned) CZ (Trial now transitioned) IT (Trial now transitioned) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2013-000122-60 | Sponsor Protocol Number: 1.0 | Start Date*: 2013-05-17 |
| Sponsor Name:Karolinska University Hospital, Division of Pediatrics/Astrid Lindgren Children´s Hospital | ||
| Full Title: The effect of dexmedetomidine as an adjuvant to local anaesthetics for ilioinguinal blocks in paediatric patients | ||
| Medical condition: Pediatric patients receive ilioinguinal-iliohypogastric nerve blockade with 0.2ml/kg ropivacaine 0.197% and 0.3µg/kg dexmedetomidine or 0.2ml/kg ropivacaine 0.197% and saline as a placebo. Aim of t... | ||
| Disease: | ||
| Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | |
| Trial protocol: SE (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2012-003251-11 | Sponsor Protocol Number: DIABGAD-1 | Start Date*: 2012-11-21 |
| Sponsor Name:Linköping university | ||
| Full Title: Pilot Trial to preserve residual insulin secretion in children and adolescents with recent onset Type 1 diabetes by using GAD-antigen (Diamyd) therapy in combination with Vitamin D and Ibuprofen . | ||
| Medical condition: Type 1 diabetes in children and adolescents | ||
| Disease: | ||
| Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
| Trial protocol: SE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2006-001563-37 | Sponsor Protocol Number: Prot-Cur 3. | Start Date*: 2006-10-10 |
| Sponsor Name:Department of Pediatrics Holbaek Hospital | ||
| Full Title: Tidlig selektiv behandling med Curosurf. Behandling af RDS efter bestemmelse af lamellar body counts på ventrikelaspirat sammenholdt med behandling ved a/APO2 <0,36 En randomiseret kontrolleret mul... | ||
| Medical condition: Respiratory Distress Syndrome (RDS) in infants 24-29 weeks`gestation | ||
| Disease: | ||
| Population Age: Preterm newborn infants, Newborns, Under 18 | Gender: Male, Female | |
| Trial protocol: DK (Completed) SE (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2018-002876-41 | Sponsor Protocol Number: 38RC18.123 | Start Date*: 2019-03-27 |
| Sponsor Name:CHU Grenoble-Alpes | ||
| Full Title: Assesment of Propofol sedation during intra tracheal surfactant administration by the LISA method (Less Invasive Surfactant Administration) | ||
| Medical condition: Respiratory Distress Syndrome of preterm babies born < 32 weeks of gestational age | ||
| Disease: | ||
| Population Age: Preterm newborn infants, Under 18 | Gender: Male, Female | |
| Trial protocol: FR (Trial now transitioned) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2009-015163-14 | Sponsor Protocol Number: 73191198 | Start Date*: 2010-01-08 | ||||||||||||||||
| Sponsor Name:Department of Pediatrics Aarhus University Hospital Skejby | ||||||||||||||||||
| Full Title: Reduction of hypertrophic scars and keloid by use of corticosteroid cream after removal of a tunneled central venous catheter in childhood cancer survivors | ||||||||||||||||||
| Medical condition: Development of hypertrophic and keloid scars after removal of tunneled central venous catheters in childhood cancer survivors | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |||||||||||||||||
| Trial protocol: DK (Completed) | ||||||||||||||||||
| Trial results: (No results available) | ||||||||||||||||||
| EudraCT Number: 2006-001721-26 | Sponsor Protocol Number: B9R-EW-GDFC(a) | Start Date*: 2006-09-25 |
| Sponsor Name:UAB “Eli Lilly Lietuva” | ||
| Full Title: The Genetics and Neuroendocrinology of Short Stature International Study (GeNeSIS) | ||
| Medical condition: Short Stature | ||
| Disease: | ||
| Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
| Trial protocol: LT (Prematurely Ended) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2015-001946-26 | Sponsor Protocol Number: AMITNED | Start Date*: 2016-01-19 |
| Sponsor Name:Aarhus University Hospital | ||
| Full Title: Amilorid treatment of nephrotic edema | ||
| Medical condition: Childhood idiopathic nephrotic syndrome (NS) | ||
| Disease: | ||
| Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | |
| Trial protocol: DK (Prematurely Ended) | ||
| Trial results: View results | ||
| EudraCT Number: 2006-004427-11 | Sponsor Protocol Number: 060317 | Start Date*: 2006-10-27 |
| Sponsor Name:Univ of Lund, Dept of Pediatrics | ||
| Full Title: Effects of Omega-3-Fatty Acids on Arterial Endothelial Function and Intima Media Thickness in Children with Insulin-Dependent Diabetes Mellitus | ||
| Medical condition: Diabetes mellitus type 1 in children | ||
| Disease: | ||
| Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
| Trial protocol: SE (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2009-010965-22 | Sponsor Protocol Number: NF1-SIMCODA | Start Date*: 2009-09-29 |
| Sponsor Name:Erasmus MC - Department of Pediatrics | ||
| Full Title: The effect of long-term simvastatin treatment on cognitive function and daily life in children with Neurofibromatosis 1: a one year randomized controlled trial | ||
| Medical condition: Neurofibromatosis 1 | ||
| Disease: | ||
| Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
| Trial protocol: NL (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2018-000566-11 | Sponsor Protocol Number: 39-2018 | Start Date*: 2018-06-05 |
| Sponsor Name:University of Oulu | ||
| Full Title: Extremely low gestational age infants' PARAcetamol Study | ||
| Medical condition: Open ductus arteriosus of a premature infant | ||
| Disease: | ||
| Population Age: Preterm newborn infants, Under 18 | Gender: Male, Female | |
| Trial protocol: FI (Completed) | ||
| Trial results: (No results available) | ||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.
